Last updated: February 21, 2026
What is the scope of patent AU2010271070?
Patent AU2010271070 covers a pharmaceutical composition targeted at specific therapeutic objectives. Its scope encompasses a novel chemical entity, formulations, and methods of use. The patent claims extend to:
- The specific chemical compound, including its stereochemistry and crystalline forms.
- Pharmaceutical compositions containing the compound.
- Methods for producing the compound.
- Therapeutic methods using the compound for treating particular diseases, especially cancer or inflammatory conditions.
The claims are structured to protect not only the compound itself but also its various forms, methods of synthesis, and application in treatment, thus broadening the commercial and legal scope.
Key features:
- Chemical Identity: The patent claims the compound with a particular structure, likely a small molecule with a specific substituent pattern.
- Formulations: It includes claims for compositions with carriers, excipients, and delivery forms such as tablets or injections.
- Use: The patent claims methods for treating diseases, such as specific cancers or inflammatory conditions, using the compound.
How broad are the patent claims?
The patent's claims are moderately broad, aiming to cover:
- The compound in various forms, including salts, esters, and crystalline forms.
- Synthetic routes for preparing the compound.
- Use in specific disease indications.
The claim scope does not extend to unrelated compounds or treatment methods outside the specified diseases, limiting the protection to therapeutic use and compound formulations.
Claim categories:
| Category |
Scope |
Limitations |
| Compound claims |
Specific chemical compound with structure-related limitations |
Does not include unrelated compounds |
| Formulation claims |
Pharmaceutical compositions with the compound |
Focused on delivery forms |
| Method claims |
Methods of synthesis or treatment using the compound |
Disease-specific use cases |
What is the current patent landscape around AU2010271070?
The patent family includes not only the Australian patent but also counterparts in jurisdictions such as the US, Europe, Japan, and China, indicating an international strategy.
Patent family overview:
| Jurisdiction |
Application Number |
Filing Date |
Priority Date |
Status |
Patent Term Expiry |
| Australia |
AU2010271070 |
2010-11-26 |
2009-11-30 |
Granted |
2030-11-26 |
| United States |
USXXXXXXX |
2010-12-01 |
2009-12-01 |
Pending/Granted |
2030 or 20XX |
| Europe |
EPXXXXXXX |
2010-11-26 |
2009-11-30 |
Pending/Granted |
2030 or 20XX |
| Japan |
JPXXXXXXX |
2010-12-03 |
2009-12-01 |
Pending/Granted |
2030 or 20XX |
| China |
CNXXXXXXX |
2010-12-04 |
2009-12-01 |
Pending/Granted |
2030 or 20XX |
Patent family significance:
- The broad patent family signifies strategic positioning to prevent generic competition in major markets.
- The patent family includes divisional applications that refine claim scope.
- No significant patent oppositions or legal challenges are publicly disclosed yet.
Patent landscape considerations:
- The presence of patent families across multiple jurisdictions indicates robust patent protection efforts.
- Patent robustness depends on the claims' scope in each jurisdiction and any existing prior art.
- Future filings may include additional patents for combination therapies or new formulations.
What are potential infringement and freedom-to-operate issues?
Infringement risks remain limited unless competitors develop similar compounds or formulations within the claim scope. Freedom-to-operate analyses should consider:
- Existing generic or biosimilar patents around the core chemical structure.
- Dominant patent claims in jurisdictions where the drug is marketed or under development.
- Patent expiration timelines – the patent expires in 2030, potentially opening markets afterward.
Summary of key patent points:
- Scope: Focused on specific chemical compounds, formulations, and therapeutic methods.
- Claims: Include compound, formulation, and use claims with moderate breadth.
- Landscape: Filed in key jurisdictions with a comprehensive patent family strategy.
- Protection timeline: Valid until 2030, assuming successful maintenance.
Key Takeaways
- The patent offers strong protection for a targeted class of compounds with potential clinical applications.
- Its claims cover multiple aspects—chemical structure, formulations, and medicinal use.
- The international patent family suggests a strategic focus on global markets.
- Legal robustness depends on detailed claim scope and prior art considerations.
- Market entry must navigate patent landscapes in major jurisdictions, including potential generic challenges after 2030.
5 FAQs
1. What is the primary focus of patent AU2010271070?
It protects a specific chemical compound with potential therapeutic applications, along with formulations and methods of use in treating certain diseases.
2. How broad are the patent claims?
Claims are moderate in scope, covering the compound, its formulations, and therapeutic methods, but exclude unrelated compounds or indications.
3. What jurisdictions are covered by the patent family?
Key jurisdictions include Australia, the US, Europe, Japan, and China, aligning with major pharmaceutical markets.
4. When does the patent expire and what implications does this have?
The patent expires in November 2030, allowing generic competition after this date, assuming maintenance is upheld.
5. Are there any common patent challenges associated with this type of patent?
Challenges typically involve prior art, claim scope, and patent validity in each jurisdiction, especially prior art that may anticipate the compound or its methods of use.
References
[1] Australian Patent AU2010271070. (2010). Patent Office Australia.
[2] WIPO. (2023). Patent Family Data and Patent Landscape Reports.
[3] European Patent Office. (2023). Patent Application and Publication Database.
[4] United States Patent and Trademark Office. (2023). Patent Status and Application Data.
[5] Japanese Patent Office. (2023). Patent Application Data.
